Insulin API is a pharmaceutical-grade recombinant human insulin used for the treatment of Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and other conditions requiring insulin therapy. Insulin is a naturally occurring peptide hormone that regulates blood glucose levels by facilitating glucose uptake into muscle and fat cells while suppressing hepatic glucose production.
Recombinant Human Insulin is produced using advanced biotechnology processes and serves as the active ingredient in various injectable insulin formulations, including rapid-acting, short-acting, intermediate-acting, long-acting, and premixed insulin products.
Manufactured under WHO-GMP-certified biopharmaceutical facilities, our Insulin API is produced using state-of-the-art recombinant DNA technology to ensure exceptional purity, biological activity, stability, and batch-to-batch consistency. Every batch undergoes rigorous analytical testing and is supplied with comprehensive documentation including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Insulin API is used in the manufacture of injectable insulin products for the treatment and management of Type 1 and Type 2 Diabetes Mellitus.
Insulin regulates blood glucose by promoting glucose uptake into cells, reducing hepatic glucose production, and supporting normal carbohydrate, fat, and protein metabolism.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Insulin API in commercial quantities for pharmaceutical and biopharmaceutical manufacturing with worldwide export support.
Get Bulk Quote via WhatsApp